Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc is set to transform the country’s pharmaceutical manufacturing industry with the construction of its new World Health Organization (WHO)-standard Biotech Plant, located in Sango Ota area of Ogun State.
The new plant will help Fidson accomplish a world-class pharmaceutical manufacturing capacity, that will in turn help it to compete healthily with its foreign counterparts, thereby placing the country’s healthcare manufacturing sector on a global pedestal.
The company’s Managing Director, Dr Fidelis Ayebae who made this known stated that presently, the company is almost exhausting its manufacturing capacity due to the volume of demands for its products by Nigerians, both at the institutional and individual level. This he said has called for a more massive manufacturing plant that can meet its growing demand.
Dr Ayebae also emphasised that when completed, the plant will be used for manufacturing large scale pharmaceutical products that will take care of the healthcare needs of Nigerians, thereby strengthening the company’s leadership position in Nigeria and global pharmaceutical sector.
The new Biotech plant construction is one of the ways Fidson Healthcare is demonstrating its commitment to the well-being of Nigerians and also fulfilling its corporate brand promise of providing excellent quality world-class healthcare solutions.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Post from PM News